Back
NewLake Capital Partners Vs. Akero Therapeutics Industry Stock Comparison
Sell
13
NLCP
NewLake Capital Partners
Last Price:
13.30
Seasonality Move:
-7.54%
Buy
59
AKRO
Akero Therapeutics
Last Price:
17.90
Seasonality Move:
-0.92%
Sell
13
NewLake Capital Partners (NLCP)
is a Sell
Is NewLake Capital Partners a Buy, Sell or Hold?
- The current NewLake Capital Partners [NLCP] share price is $13.30. The Score for NLCP is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- NLCP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $17.91. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NLCP Stock Price Chart
What is NewLake Capital Partners's stock price today?
-
The NewLake Capital Partners share price today is $13.30
The current trend is moderately bullish and NLCP is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $17.91
The current trend is relatively stagnant and AKRO is experiencing slight selling pressure.
NLCP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 53.85 | Buy |
| Chaikin Money Flow: | -22656 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.8 - 13.28) | Buy |
| Bollinger Bands (100): | (12.7 - 13.86) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 53.25 | Buy |
| Chaikin Money Flow: | -55617 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.57 - 16.71) | Buy |
| Bollinger Bands (100): | (18.32 - 50.24) | Sell |
NLCP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.24 | Buy |
| 20-day SMA: | 13.13 | Buy |
| 50-day SMA: | 13.21 | Buy |
| 200-day SMA: | 13.33 | Sell |
| 8-day EMA: | 13.27 | Buy |
| 20-day EMA: | 13.19 | Buy |
| 50-day EMA: | 13.2 | Buy |
| 200-day EMA: | 13.95 | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.73 | Buy |
| 20-day SMA: | 15.69 | Buy |
| 50-day SMA: | 21.8 | Sell |
| 200-day SMA: | 39.48 | Sell |
| 8-day EMA: | 16.85 | Buy |
| 20-day EMA: | 16.52 | Buy |
| 50-day EMA: | 21.96 | Sell |
| 200-day EMA: | 34.46 | Sell |
NewLake Capital Partners Earnings Growth & NLCP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.06 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.77 per share.
NewLake Capital Partners Technical Analysis
| Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||